AstraZeneca has ended work on one of its potential drugs for fatty liver disease after viewing disappointing data from a ...

Final Data from VAX-24 Infant Phase 2 Dose-Finding Study Consistent with Previously Reported Positive Interim Data; Provide ...

Eli Lilly has linked its amylin agonist eloralintide to up to 20.1% weight loss at Week 48, encouraging the drugmaker to ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...

In patients with advanced chronic kidney disease (CKD) and diabetes, treatment with rilparencel resulted in statistically significant and clinically meaningful slowing of CKD progressionBilateral ...

Adagene has dosed the first participant in its open label, randomised Phase II trial studying muzastotug (ADG126), along with ...

CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has ...

An official groundbreaking for Phase 2 of the master plan for The Ranch Events Complex will be held next Tuesday, with work ...

In a Tuesday release, Catawba College announced the launch of Phase II of its plan to enhance Newman Park, ushering in a new ...

The Indian Air Force has announced the Agniveer Vayu Phase 1 2025 results for the February 2026 intake. Candidates can check ...